CINCINNATI--(BUSINESS WIRE)--Jan. 9, 2015--
Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today
announced its wholly owned subsidiary, Meridian Life Science, Inc. (MLS)
has opened a new office in Beijing, China. The office is located on
Chang-An Avenue (close to Tiananmen Square and government offices) on
the 15th floor in the New China Life Insurance (NCI) Tower
Center, in the heart of the central business district (CBD) of Beijing.
Over the years, Meridian has established close relationships with major
IVD companies in China by providing high quality and competitive
antigens, antibodies, and blockers for in vitro commercial
assays. Meridian’s commitment and support to IVD customers in China will
be greatly enhanced with local representation.
Lourdes Weltzien, Ph.D., Vice President and General Manager of Meridian
Life Science, Inc. stated, “We are excited to open our office in Beijing
and bring local support and representation to our important customers in
China. We have been delighted to build important and close working
relationships with our Chinese customers over the past several years.
Now, we are even more excited to demonstrate our increased commitment to
our Chinese customers by adding local resources to better service their
needs for high quality life science products. Our business in China is
growing rapidly and we are committed to continue our investments in such
an important market.”
ABOUT MERIDIAN BIOSCIENCE, INC.
Meridian is a fully integrated life science company that develops,
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, purified reagents and related products and offers
biopharmaceutical enabling technologies. Utilizing a variety of methods,
these products and diagnostic tests provide accuracy, simplicity and
speed in the early diagnosis and treatment of common medical conditions,
such as gastrointestinal, viral and respiratory infections. Meridian’s
diagnostic products are used outside of the human body and require
little or no special equipment. The Company's products are designed to
enhance patient well-being while reducing the total outcome costs of
healthcare. Meridian has strong market positions in the areas of
gastrointestinal and upper respiratory infections, serology,
parasitology and fungal disease diagnosis. In addition, Meridian is a
supplier of rare reagents, specialty biologicals and related
technologies used by biopharmaceutical companies engaged in research for
new drugs and vaccines. The Company markets its products and
technologies to hospitals, reference laboratories, research centers,
diagnostics manufacturers and biotech companies in more than 60
countries around the world. The Company’s shares are traded on NASDAQ’s
Global Select Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.
ADDITIONAL INFORMATION
For more information about Bioline, please visit www.bioline.com
For
more information about Meridian Life Science, Inc., please visit www.meridianlifescience.com
For
more information about Meridian Bioscience, Inc., please visit www.meridianbioscience.com
Richard
L. Eberly, rick.eberly@meridianbioscience.com
Source: Meridian Bioscience, Inc.
Meridian Bioscience, Inc.
Richard L. Eberly, 513-271-3700
rick.eberly@meridianbioscience.com
